JUPITER WELLNESS INC (JUPW) Fundamental Analysis & Valuation

NASDAQ:JUPWUS48208F1057

Current stock price

1.52 USD
+0.16 (+11.76%)
At close:
1.5 USD
-0.02 (-1.32%)
After Hours:

This JUPW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. JUPW Profitability Analysis

1.1 Basic Checks

  • JUPW had negative earnings in the past year.
  • In the past year JUPW has reported a negative cash flow from operations.
JUPW Yearly Net Income VS EBIT VS OCF VS FCFJUPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -5M -10M -15M -20M -25M

1.2 Ratios

  • The profitability ratios for JUPW are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JUPW Yearly ROA, ROE, ROICJUPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 -100 -200 -300 -400

1.3 Margins

  • With a Gross Margin value of 19.36%, JUPW is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
  • JUPW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JUPW Yearly Profit, Operating, Gross MarginsJUPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -2K -4K -6K -8K

5

2. JUPW Health Analysis

2.1 Basic Checks

  • JUPW does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, JUPW has less shares outstanding
  • Compared to 1 year ago, JUPW has a worse debt to assets ratio.
JUPW Yearly Shares OutstandingJUPW Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M 15M 20M
JUPW Yearly Total Debt VS Total AssetsJUPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

  • JUPW has an Altman-Z score of -4.45. This is a bad value and indicates that JUPW is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -4.45, JUPW is doing worse than 85.00% of the companies in the same industry.
  • JUPW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.45
ROIC/WACCN/A
WACC9%
JUPW Yearly LT Debt VS Equity VS FCFJUPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 5M -5M 10M 15M

2.3 Liquidity

  • JUPW has a Current Ratio of 1.84. This is a normal value and indicates that JUPW is financially healthy and should not expect problems in meeting its short term obligations.
  • JUPW has a Current ratio (1.84) which is in line with its industry peers.
  • A Quick Ratio of 1.77 indicates that JUPW should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.77, JUPW is doing good in the industry, outperforming 77.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.77
JUPW Yearly Current Assets VS Current LiabilitesJUPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 5M 10M 15M

3

3. JUPW Growth Analysis

3.1 Past

  • JUPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.65%, which is quite impressive.
  • JUPW shows a small growth in Revenue. In the last year, the Revenue has grown by 0.13%.
  • JUPW shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 752.55% yearly.
EPS 1Y (TTM)50.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.46%
Revenue 1Y (TTM)0.13%
Revenue growth 3Y752.55%
Revenue growth 5YN/A
Sales Q2Q%-21.17%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JUPW Yearly Revenue VS EstimatesJUPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2M 4M 6M

0

4. JUPW Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for JUPW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JUPW Price Earnings VS Forward Price EarningsJUPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JUPW Per share dataJUPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. JUPW Dividend Analysis

5.1 Amount

  • No dividends for JUPW!.
Industry RankSector Rank
Dividend Yield N/A

JUPW Fundamentals: All Metrics, Ratios and Statistics

JUPITER WELLNESS INC

NASDAQ:JUPW (9/14/2023, 9:36:58 PM)

After market: 1.5 -0.02 (-1.32%)

1.52

+0.16 (+11.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-15
Earnings (Next)11-13
Inst Owners18.91%
Inst Owner Change-68.59%
Ins Owners18.74%
Ins Owner Change0%
Market Cap41.28M
Revenue(TTM)5.96M
Net Income(TTM)-12.53M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.92
P/FCF N/A
P/OCF N/A
P/B 7.28
P/tB 9.23
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.22
BVpS0.21
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.36%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.32%
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.77
Altman-Z -4.45
F-Score4
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)52.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.13%
Revenue growth 3Y752.55%
Revenue growth 5YN/A
Sales Q2Q%-21.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.52%
OCF growth 3YN/A
OCF growth 5YN/A

JUPITER WELLNESS INC / JUPW Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for JUPITER WELLNESS INC?

ChartMill assigns a fundamental rating of 2 / 10 to JUPW.


What is the valuation status for JUPW stock?

ChartMill assigns a valuation rating of 0 / 10 to JUPITER WELLNESS INC (JUPW). This can be considered as Overvalued.


How profitable is JUPITER WELLNESS INC (JUPW) stock?

JUPITER WELLNESS INC (JUPW) has a profitability rating of 0 / 10.


What is the financial health of JUPITER WELLNESS INC (JUPW) stock?

The financial health rating of JUPITER WELLNESS INC (JUPW) is 5 / 10.